272 related articles for article (PubMed ID: 11472263)
1. Physiochemical aspects of tubulin-interacting antimitotic drugs.
Correia JJ; Lobert S
Curr Pharm Des; 2001 Sep; 7(13):1213-28. PubMed ID: 11472263
[TBL] [Abstract][Full Text] [Related]
2. Effects of antimitotic agents on tubulin-nucleotide interactions.
Correia JJ
Pharmacol Ther; 1991 Nov; 52(2):127-47. PubMed ID: 1818332
[TBL] [Abstract][Full Text] [Related]
3. Modulation of microtubule dynamics by drugs: a paradigm for the actions of cellular regulators.
Wilson L; Panda D; Jordan MA
Cell Struct Funct; 1999 Oct; 24(5):329-35. PubMed ID: 15216890
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
Smith CD; Zhang X
J Biol Chem; 1996 Mar; 271(11):6192-8. PubMed ID: 8626409
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of antitumor drugs that interact with microtubules and tubulin.
Jordan MA
Curr Med Chem Anticancer Agents; 2002 Jan; 2(1):1-17. PubMed ID: 12678749
[TBL] [Abstract][Full Text] [Related]
6. Interaction of cryptophycin 1 with tubulin and microtubules.
Kerksiek K; Mejillano MR; Schwartz RE; Georg GI; Himes RH
FEBS Lett; 1995 Dec; 377(1):59-61. PubMed ID: 8543019
[TBL] [Abstract][Full Text] [Related]
7. Antimicrotubular drugs binding to vinca domain of tubulin.
Gupta S; Bhattacharyya B
Mol Cell Biochem; 2003 Nov; 253(1-2):41-7. PubMed ID: 14619954
[TBL] [Abstract][Full Text] [Related]
8. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
9. Dynamic instability of microtubules: Monte Carlo simulation and application to different types of microtubule lattice.
Martin SR; Schilstra MJ; Bayley PM
Biophys J; 1993 Aug; 65(2):578-96. PubMed ID: 8218889
[TBL] [Abstract][Full Text] [Related]
10. Microtubule structure at improved resolution.
Meurer-Grob P; Kasparian J; Wade RH
Biochemistry; 2001 Jul; 40(27):8000-8. PubMed ID: 11434769
[TBL] [Abstract][Full Text] [Related]
11. Microtubule Targeting Agents as Cancer Chemotherapeutics: An Overview of Molecular Hybrids as Stabilizing and Destabilizing Agents.
Tangutur AD; Kumar D; Krishna KV; Kantevari S
Curr Top Med Chem; 2017; 17(22):2523-2537. PubMed ID: 28056738
[TBL] [Abstract][Full Text] [Related]
12. Determination of the net exchange rate of tubulin dimer in steady-state microtubules by fluorescence correlation spectroscopy.
Neumann T; Kirschstein SO; Camacho Gomez JA; Kittler L; Unger E
Biol Chem; 2001 Mar; 382(3):387-91. PubMed ID: 11347885
[TBL] [Abstract][Full Text] [Related]
13. Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site.
Mooberry SL; Taoka CR; Busquets L
Cancer Lett; 1996 Oct; 107(1):53-7. PubMed ID: 8913266
[TBL] [Abstract][Full Text] [Related]
14. Interactions of antimitotic peptides and depsipeptides with tubulin.
Hamel E
Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents.
Shi Q; Chen K; Morris-Natschke SL; Lee KH
Curr Pharm Des; 1998 Jun; 4(3):219-48. PubMed ID: 10197041
[TBL] [Abstract][Full Text] [Related]
16. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
Bai RL; Pettit GR; Hamel E
J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics.
Downing KH
Annu Rev Cell Dev Biol; 2000; 16():89-111. PubMed ID: 11031231
[TBL] [Abstract][Full Text] [Related]
18. Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin.
Sáez-Calvo G; Sharma A; Balaguer FA; Barasoain I; Rodríguez-Salarichs J; Olieric N; Muñoz-Hernández H; Berbís MÁ; Wendeborn S; Peñalva MA; Matesanz R; Canales Á; Prota AE; Jímenez-Barbero J; Andreu JM; Lamberth C; Steinmetz MO; Díaz JF
Cell Chem Biol; 2017 Jun; 24(6):737-750.e6. PubMed ID: 28579361
[TBL] [Abstract][Full Text] [Related]
19. High-resolution microtubule structures reveal the structural transitions in αβ-tubulin upon GTP hydrolysis.
Alushin GM; Lander GC; Kellogg EH; Zhang R; Baker D; Nogales E
Cell; 2014 May; 157(5):1117-29. PubMed ID: 24855948
[TBL] [Abstract][Full Text] [Related]
20. Taxol allosterically alters the dynamics of the tubulin dimer and increases the flexibility of microtubules.
Mitra A; Sept D
Biophys J; 2008 Oct; 95(7):3252-8. PubMed ID: 18621813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
